Gempharmatech Co. Ltd. A (688046) — Cash Flow-to-Debt Ratio
Gempharmatech Co. Ltd. A (688046) has a Cash Flow-to-Debt Ratio of 0.21x as of December 2024, meaning its operating cash flow of CN¥90.31 Million could theoretically repay 0% of its total liabilities (CN¥437.92 Million) in one year. See Gempharmatech Co. Ltd. A free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Gempharmatech Co. Ltd. A Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Gempharmatech Co. Ltd. A across 6 annual periods. Also explore net asset growth rate of Gempharmatech Co. Ltd. A to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Gempharmatech Co. Ltd. A (2019–2024)
Year-by-year debt coverage analysis for Gempharmatech Co. Ltd. A. For market capitalisation and broader financial context, see how much is Gempharmatech Co. Ltd. A worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.21x | CN¥90.31 Million | CN¥437.92 Million | ▼ -19.9% |
| 2023 | 0.26x | CN¥116.57 Million | CN¥452.93 Million | ▼ -33.0% |
| 2022 | 0.38x | CN¥105.98 Million | CN¥276.00 Million | ▼ -8.9% |
| 2021 | 0.42x | CN¥113.31 Million | CN¥268.78 Million | ▼ -26.6% |
| 2020 | 0.57x | CN¥129.79 Million | CN¥225.95 Million | ▲ +30.2% |
| 2019 | 0.44x | CN¥65.12 Million | CN¥147.66 Million | — |